Expression and distribution of InsP3 receptor subtypes in proliferating vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 273, Issue 3, 2000, Pages 907-912

  Tasker, Paul N ^a   Taylor, Colin W ^b   Nixon, Graeme F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Inositol 1,4,5 trisphosphate receptors; Smooth muscle; Vascular

Indexed keywords

ANTIBODY; INOSITOL TRISPHOSPHATE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL NUCLEUS; CELL PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034647578     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3036     Document Type: Article

References (30)

1. Ehrlich B. E., Watras J. Inositol 1,4,5-trisphosphate activates a channel from smooth muscle sarcoplasmic reticulum. Nature. 336:1988;583-586.
2. 2+ release and contraction induced by photolysis of caged D-myo-inositol 1,4,5-trisphosphate in smooth muscle. J. Biol. Chem. 267:1992;22316-22322.
3. 400. Nature. 342:1989;32-38.
4. 3 receptor. EMBO J. 10:1991;3199-3206.
5. 3R-3, expressed in pancreatic islets, kidney, gastrointestinal tract, and other tissues. J. Biol. Chem. 268:1993;11356-11363.
6. Maranto A. R. Primary structure, ligand binding, and localization of the human type 3 Inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J. Biol. Chem. 269:1994;1222-1230.
7. Taylor C. W., Genazzani A. A., Morris S. A. Expression of inositol trisphosphate receptors. Cell Calcium. 26:1999;237-251.
8. Nixon G. F., Mignery G. A., Somlyo A. V. Immunogold localization of inositol 1,4,5-trisphosphate receptors and characterization of ultrastructural features of the sarcoplasmic reticulum in phasic and tonic smooth muscle. J. Muscle Res. Cell Motil. 15:1994;682-700.
9. Tasker P. N., Michelangeli F., Nixon G. F. Expression and distribution of the type 1 and type 3 inositol 1,4,5-trisphosphate receptor in developing vascular smooth muscle. Circ. Res. 84:1999;536-542.
10. Sugiyama T., Hasegawa K., Yanai N., Mikoshiba K., Obinata M., Matsuda Y. Alteration of the increase in intracellular calcium in proliferating smooth muscle cells. Biochem. Biophys. Res. Commun. 264:1999;774-776.
11. Cardy T. J. A., Traynor D., Taylor C. W. Differential regulation of types 1 and 3 inositol trisphosphate receptors by cytosolic calcium. Biochem. J. 328:1997;785-793.
12. 3 receptors. Biochem. J. 322:1997;591-596.
13. 3. J. Biol. Chem. 269:1994;28613-28619.
14. Owens G. K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75:1995;487-517.
15. Mosse P. R., Campbell G. R., Campbell J. H. Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media. Arteriosclerosis. 6:1986;664-669.
16. Kocher O., Gabbiani F., Gabbiani G., Reidy M. A., Cokay M. S., Peters H., Huttne I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphological studies. Lab. Invest. 65:1991;459-470.
17. Ross R., Wight T. N., Strndness E., Thiele B. Human atherosclerosis. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am. J. Pathol. 114:1984;79-93.
18. Nixon G. F., Hamilton C. A., Wadsworth R. M., Reid J. L. Comparison of endothelin-1 and noradrenaline stimulated inositol phosphate formation in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar Kyoto rats. Blood Pressure. 2:1993;221-227.
19. Frid G. M., Shekhonin B. V., Koteliansky V. E., Glukhova M. A. Phenotypic changes of human smooth muscle cells during development: Late expression of heavy caldesmon and calponin. Dev. Biol. 153:1992;185-193.
20. 2+-independent inhibition of type 1 inositol trisphosphate receptors. Biochem. J. 334:1998;447-455.
21. Wojcikiewicz R. J. H. Type I, II & III inositol trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J. Biol. Chem. 270:1995;11678-11683.
22. 2+ signalling. Curr. Opin. Neurobiol. 7:1997;339-345.
23. 2+ from the nuclear envelope. Cell. 80:1995;439-444.
24. Ross C. A., Meldolesi J., Milner T. A., Satoh T., Supattapone S., Snyder S. H. Inositol 1,4,5-trisphosphate receptor localized to endoplasmic-reticulum in cerebellar purkinje neurons. Nature. 339:1989;468-470.
25. Sugiyama T., Matsuda Y., Mikoshiba K. Inositol 1,4,5-trisphosphate receptor associated with focal contact cytoskeletal proteins. FEBS Lett. 466:2000;29-34.
26. Dolmetsch R. E., Xu K., Lewis R. S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature. 392:1998;933-936.
27. 2+ spike frequency can optimize gene expression. Nature. 392:1998;936-941.
28. 3 receptor subtypes. EMBO J. 18:1999;1303-1308.
29. 2+-independent in the mouse oocyte. J. Cell Biol. 117:1992;799-811.
30. 2+ to CREB activation and gene expression in intact cerebral arteries from mouse. Circ. Res. 86:2000;760-767.